Over the past couple of years, ambient scribes have earned widespread adoption among health systems. While there's excitement ...

AHIP executives discussed the impact the proposed budget bill could have on Medicaid and the individual market.

To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider ...

The emergence of large language models (LLMs) prompted one research team to compare how well this technology performs compared with traditional clinical decision support systems in identifying ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than ...

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express ...

Amid an escalating overdose crisis, growing attention has turned to racial and ethnic disparities in the accessibility of medication-assisted treatment (MAT), such as buprenorphine. Most existing ...

Behavioral health was once dismissed as secondary: unseen, underfunded, and misunderstood. Not anymore. Its stigma has faded, and the financial cost of neglecting it is too steep to ignore.

If enacted, the GOP’s spending bill could kick more than 10 million Americans off Medicaid. Experts are worried about the ...

Moderna has interim data it says support advancing its avian influenza vaccine into a late-stage clinical trial, but the U.S. government has canceled the federal contract that would have financed ...

Our Season 2 – Innovations in Oncology – continues with a focus on precision medicine. I talk with CEO of Helix, James Lu, who had an interesting take on how precision medicine is evolving.